Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACB vs ACB + Saphenous Nerve Block for ACL Repair Pain
NCT04443634Unknown
- Sponsor
- Cairo University
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by Cairo University. Primary endpoint: Total dose of morphine consumption at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04443634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443634.